Literature DB >> 28146639

Fifty Years of Research in ARDS. Setting Positive End-Expiratory Pressure in Acute Respiratory Distress Syndrome.

Sarina K Sahetya1, Ewan C Goligher2,3, Roy G Brower1.   

Abstract

Positive end-expiratory pressure (PEEP) has been used during mechanical ventilation since the first description of acute respiratory distress syndrome (ARDS). In the subsequent decades, many different strategies for optimally titrating PEEP have been proposed. Higher PEEP can improve arterial oxygenation, reduce tidal lung stress and strain, and promote more homogenous ventilation by preventing alveolar collapse at end expiration. However, PEEP may also cause circulatory depression and contribute to ventilator-induced lung injury through alveolar overdistention. The overall effect of PEEP is primarily related to the balance between the number of alveoli that are recruited to participate in ventilation and the amount of lung that is overdistended when PEEP is applied. Techniques to assess lung recruitment from PEEP may help to direct safer and more effective PEEP titration. Some PEEP titration strategies attempt to weigh beneficial effects on arterial oxygenation and on prevention of cyclic alveolar collapse with the harmful potential of overdistention. One method for PEEP titration is a PEEP/FiO2 table that prioritizes support for arterial oxygenation. Other methods set PEEP based on mechanical parameters, such as the plateau pressure, respiratory system compliance, or transpulmonary pressure. No single method of PEEP titration has been shown to improve clinical outcomes compared with other approaches of setting PEEP. Future trials should focus on identifying individuals who respond to higher PEEP with recruitment and on clinically important outcomes (e.g., mortality).

Entities:  

Keywords:  acute respiratory distress syndrome (ARDS); mechanical ventilation; positive end-expiratory pressure (PEEP)

Mesh:

Year:  2017        PMID: 28146639      PMCID: PMC5470753          DOI: 10.1164/rccm.201610-2035CI

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  79 in total

1.  IMPROVED TECHNIQUE FOR ESTIMATING PLEURAL PRESSURE FROM ESOPHAGEAL BALLOONS.

Authors:  J MILIC-EMILI; J MEAD; J M TURNER; E M GLAUSER
Journal:  J Appl Physiol       Date:  1964-03       Impact factor: 3.531

2.  Continuous positive-pressure breathing (CPPB) in adult respiratory distress syndrome.

Authors:  D G Ashbaugh; T L Petty; D B Bigelow; T M Harris
Journal:  J Thorac Cardiovasc Surg       Date:  1969-01       Impact factor: 5.209

3.  Stress distribution in lungs: a model of pulmonary elasticity.

Authors:  J Mead; T Takishima; D Leith
Journal:  J Appl Physiol       Date:  1970-05       Impact factor: 3.531

4.  Lung Recruitment Assessed by Respiratory Mechanics and Computed Tomography in Patients with Acute Respiratory Distress Syndrome. What Is the Relationship?

Authors:  Davide Chiumello; Antonella Marino; Matteo Brioni; Irene Cigada; Federica Menga; Andrea Colombo; Francesco Crimella; Ilaria Algieri; Massimo Cressoni; Eleonora Carlesso; Luciano Gattinoni
Journal:  Am J Respir Crit Care Med       Date:  2016-06-01       Impact factor: 21.405

5.  High inflation pressure pulmonary edema. Respective effects of high airway pressure, high tidal volume, and positive end-expiratory pressure.

Authors:  D Dreyfuss; P Soler; G Basset; G Saumon
Journal:  Am Rev Respir Dis       Date:  1988-05

6.  Bedside ultrasound assessment of positive end-expiratory pressure-induced lung recruitment.

Authors:  Belaïd Bouhemad; Hélène Brisson; Morgan Le-Guen; Charlotte Arbelot; Qin Lu; Jean-Jacques Rouby
Journal:  Am J Respir Crit Care Med       Date:  2010-09-17       Impact factor: 21.405

Review 7.  Ventilator-induced lung injury: lessons from experimental studies.

Authors:  D Dreyfuss; G Saumon
Journal:  Am J Respir Crit Care Med       Date:  1998-01       Impact factor: 30.528

8.  Open Lung Approach for the Acute Respiratory Distress Syndrome: A Pilot, Randomized Controlled Trial.

Authors:  Robert M Kacmarek; Jesús Villar; Demet Sulemanji; Raquel Montiel; Carlos Ferrando; Jesús Blanco; Younsuck Koh; Juan Alfonso Soler; Domingo Martínez; Marianela Hernández; Mauro Tucci; Joao Batista Borges; Santiago Lubillo; Arnoldo Santos; Juan B Araujo; Marcelo B P Amato; Fernando Suárez-Sipmann
Journal:  Crit Care Med       Date:  2016-01       Impact factor: 7.598

9.  Accuracy and precision of end-expiratory lung-volume measurements by automated nitrogen washout/washin technique in patients with acute respiratory distress syndrome.

Authors:  Jean Dellamonica; Nicolas Lerolle; Cyril Sargentini; Gaetan Beduneau; Fabiano Di Marco; Alain Mercat; Jean-Christophe M Richard; Jean-Luc Diehl; Jordi Mancebo; Jean-Jacques Rouby; Qin Lu; Gilles Bernardin; Laurent Brochard
Journal:  Crit Care       Date:  2011-12-07       Impact factor: 9.097

10.  Nitrogen washout/washin, helium dilution and computed tomography in the assessment of end expiratory lung volume.

Authors:  Davide Chiumello; Massimo Cressoni; Monica Chierichetti; Federica Tallarini; Marco Botticelli; Virna Berto; Cristina Mietto; Luciano Gattinoni
Journal:  Crit Care       Date:  2008-12-01       Impact factor: 9.097

View more
  46 in total

1.  Erratum: Fifty Years of Research in ARDS. Setting Positive End-Expiratory Pressure in Acute Respiratory Distress Syndrome.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2018-03-01       Impact factor: 21.405

2.  Pharmacological modulation of C-X-C motif chemokine receptor 4 influences development of acute respiratory distress syndrome after lung ischaemia-reperfusion injury.

Authors:  Sean P Nassoiy; Favin S Babu; Heather M LaPorte; Matthias Majetschak
Journal:  Clin Exp Pharmacol Physiol       Date:  2017-09-20       Impact factor: 2.557

Review 3.  Fifty Years of Research in ARDS. Vt Selection in Acute Respiratory Distress Syndrome.

Authors:  Sarina K Sahetya; Jordi Mancebo; Roy G Brower
Journal:  Am J Respir Crit Care Med       Date:  2017-12-15       Impact factor: 21.405

4.  Driving Pressure Is Associated With Outcome in Pediatric Acute Respiratory Failure.

Authors:  Patrick van Schelven; Alette A Koopman; Johannes G M Burgerhof; Dick G Markhorst; Robert G T Blokpoel; Martin C J Kneyber
Journal:  Pediatr Crit Care Med       Date:  2022-03-01       Impact factor: 3.624

Review 5.  Beyond Low Tidal Volume Ventilation: Treatment Adjuncts for Severe Respiratory Failure in Acute Respiratory Distress Syndrome.

Authors:  Vikram Fielding-Singh; Michael A Matthay; Carolyn S Calfee
Journal:  Crit Care Med       Date:  2018-11       Impact factor: 7.598

Review 6.  Invasive Mechanical Ventilation.

Authors:  James M Walter; Thomas C Corbridge; Benjamin D Singer
Journal:  South Med J       Date:  2018-12       Impact factor: 0.954

7.  High versus low positive end-expiratory pressure (PEEP) levels for mechanically ventilated adult patients with acute lung injury and acute respiratory distress syndrome.

Authors:  Roberto Santa Cruz; Fernando Villarejo; Celica Irrazabal; Agustín Ciapponi
Journal:  Cochrane Database Syst Rev       Date:  2021-03-30

8.  Revisiting Old Friends: Adjunctive Therapies in Acute Respiratory Distress Syndrome.

Authors:  Catherine A Gao; Ruben J Mylvaganam; Taylor A Poor; James M Walter
Journal:  Am J Respir Crit Care Med       Date:  2021-08-15       Impact factor: 21.405

9.  Response to Ventilator Adjustments for Predicting Acute Respiratory Distress Syndrome Mortality. Driving Pressure versus Oxygenation.

Authors:  Nadir Yehya; Carol L Hodgson; Marcelo B P Amato; Jean-Christophe Richard; Laurent J Brochard; Alain Mercat; Ewan C Goligher
Journal:  Ann Am Thorac Soc       Date:  2021-05

10.  Higher versus lower positive end-expiratory pressure in patients without acute respiratory distress syndrome: a meta-analysis of randomized controlled trials.

Authors:  Tommaso Pettenuzzo; Annalisa Boscolo; Alessandro De Cassai; Nicolò Sella; Francesco Zarantonello; Paolo Persona; Laura Pasin; Giovanni Landoni; Paolo Navalesi
Journal:  Crit Care       Date:  2021-07-15       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.